Dialysis News and Research RSS Feed - Dialysis News and Research

When your kidneys are healthy, they clean your blood. They also make hormones that keep your bones strong and your blood healthy. When your kidneys fail, you need treatment to replace the work your kidneys used to do. Unless you have a kidney transplant, you will need a treatment called dialysis.

There are two main types of dialysis: hemodialysis and peritoneal dialysis. Both types filter your blood to rid your body of harmful wastes, extra salt and water. Hemodialysis does that with a machine. Peritoneal dialysis uses the lining of your abdomen, called the peritoneal membrane, to filter your blood. Each type has both risks and benefits. They also require that you follow a special diet. Your doctor can help you decide the best type of dialysis for you.
Penn researchers find effective way to inhibit inflammatory response during kidney dialysis

Penn researchers find effective way to inhibit inflammatory response during kidney dialysis

Frequent kidney dialysis is essential for the approximately 350,000 end-stage renal disease (ESRD) patients in the United States. But it can also cause systemic inflammation, leading to complications such as cardiovascular disease and anemia, and patients who rely on the therapy have a five-year survival rate of only 35 percent. Such inflammation can be triggered when the complement cascade, part of the body's innate immune system, is inadvertently activated by modern polymer-based dialysis blood filters. [More]

Elsevier launches Journal of Vascular Surgery Cases

Elsevier, a world-leading provider of scientific, technical, and medical information products and services, announced today the launch of Journal of Vascular Surgery Cases, a new open access, online-only journal dedicated to publishing peer-reviewed, high quality case reports related to all aspects of arterial, venous, and lymphatic diseases, including the placement and maintenance of arterio-venous dialysis access, with an emphasis on the practicing clinician. [More]
Verizon announces winners of 2014 Powerful Answers Award

Verizon announces winners of 2014 Powerful Answers Award

The wait is over. Verizon is proud to announce the winners of Verizon's 2014 Powerful Answers Award, three in each of the following categories: education, health care, sustainability and transportation. [More]
New therapeutic targets can prevent scarring within transplanted kidneys

New therapeutic targets can prevent scarring within transplanted kidneys

Kidneys donated by people born with a small variation in the code of a key gene may be more likely, once in the transplant recipient, to accumulate scar tissue that contributes to kidney failure, according to a study led by researchers at the Icahn School of Medicine at Mount Sinai and published today in the Journal of Clinical Investigation. [More]
Alport syndrome: an interview with Dr Paul Grint, CMO, Regulus

Alport syndrome: an interview with Dr Paul Grint, CMO, Regulus

Alport Syndrome was first described by a physician called Cecil Alport, back in the late 1920s. It's a genetic disease that affects a certain type of collagen involved in the functioning of the kidney, the ear, and the eye. [More]
DaVita HealthCare Partners earns over 30 awards for excellence in 2014

DaVita HealthCare Partners earns over 30 awards for excellence in 2014

DaVita HealthCare Partners Inc., one of the nation's largest and most innovative health care communities, today confirmed earning over 30 awards for excellence from independent organizations in 2014. [More]
Presence of certain proteins in HDL can lead to cardiovascular risk

Presence of certain proteins in HDL can lead to cardiovascular risk

A current study by the MedUni Vienna has shown that changes to the "good cholesterol" HDL (High-Density Lipoprotein) can be associated with cardiovascular diseases: by developing a new laboratory test, scientists at the Institute of Medical Genetics and the Department of Nephrology & Dialysis (University Department of Internal Medicine III) at the MedUni Vienna have demonstrated for the first time that the presence of certain proteins in the HDL can lead to an increased risk of cardiovascular disease and mortality. [More]
UL professor awarded HRB grant to improve understanding of Acute Kidney Injury

UL professor awarded HRB grant to improve understanding of Acute Kidney Injury

It is estimated that at least 1 in 5 hospitalised adults develop Acute Kidney Injury (AKI). Emerging evidence suggests that AKI: is under-recognised in clinical practice; predicts an accelerated risk of end-stage kidney disease (ESKD), and may be a risk amplifier for many other chronic diseases with death rates in excess of 20%. [More]
University of Vermont Medical Center recognized with 2014 Partnership in Prevention Award

University of Vermont Medical Center recognized with 2014 Partnership in Prevention Award

The U.S. Department of Health and Human Services, the Association for Professionals in Infection Control and Epidemiology, and the Society for Healthcare Epidemiology of America today recognized the University of Vermont Medical Center with the 2014 Partnership in Prevention Award for achieving sustainable improvements toward eliminating healthcare-associated infections (HAIs). [More]
Kidney disease patients can benefit from simple and structured exercise

Kidney disease patients can benefit from simple and structured exercise

Simple yet structured exercise can significantly improve kidney disease patients' quality of life as well as decrease their pain, according to a study appearing in an upcoming issue of the Clinical Journal of the American Society of Nephrology (CJASN). [More]
Majority of kidney dialysis patients not adequately prepared for emergency or natural disaster

Majority of kidney dialysis patients not adequately prepared for emergency or natural disaster

Eighty percent of kidney dialysis patients surveyed were not adequately prepared in the event of an emergency or natural disaster that shut down their dialysis center. [More]

OSU engineers identify method to prepare frozen red blood cells for transfusions

Engineers at Oregon State University have identified a method to rapidly prepare frozen red blood cells for transfusions, which may offer an important new way to manage the world's blood supply. [More]
NIH study finds limited kidney benefit from more rigorous blood pressure treatment

NIH study finds limited kidney benefit from more rigorous blood pressure treatment

Using two drugs was no more effective than a single drug in slowing disease progression in people with autosomal dominant polycystic kidney disease (ADPKD), according to two studies funded by the National Institutes of Health. One of the studies also showed that rigorous blood pressure treatment slowed growth of kidney cysts, a marker of ADPKD, but had little effect on kidney function compared to standard blood pressure treatment. [More]
DaVita Kidney Care, Medtronic partner to better understand cardiovascular health in ESRD patients

DaVita Kidney Care, Medtronic partner to better understand cardiovascular health in ESRD patients

DaVita Kidney Care, a division of DaVita HealthCare Partners Inc. and leading provider of kidney care services, announced today a collaboration with Medtronic, Inc., to better understand cardiovascular health in end stage renal disease (ESRD) patients. [More]

DaVita HealthCare Partners to build 'Wall of Honor for Veterans'

DaVita HealthCare Partners Inc., one of the nation's largest and most innovative health care communities, today honors the men and women of the armed forces who have selflessly served the United States. [More]

DaVita HealthCare Partners, Centura Health to jointly help optimize health care in Colorado, Kansas

Centura Health and DaVita HealthCare Partners Inc. today announced a new joint venture that will offer a differentiated health care delivery model to help optimize health care value and lower costs for consumers in Colorado and Kansas. The two partners will combine their expertise to provide enhanced resources that increase coordination of care, equip care providers with sophisticated analytical tools and focus on prevention. [More]
Hospira launches Paricalcitol Injection

Hospira launches Paricalcitol Injection

Hospira, Inc., the world's leading provider of injectable drugs and infusion technologies, today announced the launch of Paricalcitol Injection, a generic version of AbbVie's Zemplar. Hospira obtained U.S. Food and Drug Administration approval of paricalcitol on Oct. 21 and launched the product Nov. 1. [More]
New dialysis decision aid can benefit patients with kidney failure

New dialysis decision aid can benefit patients with kidney failure

A KIDNEY dialysis decision aid, enabling patients with decreasing kidney function to better assess which treatment is right for them, has been developed by Kidney Research UK as part of a study in which Sheffield Teaching Hospitals NHS Foundation Trust was involved. [More]
Davita Kidney Care joins fight against diabetes during National Diabetes Month

Davita Kidney Care joins fight against diabetes during National Diabetes Month

DaVita Kidney Care, a division of DaVita HealthCare Partners Inc. (NYSE: DVA) and a leading provider of kidney care services, joins the fight against diabetes during National Diabetes Month this November by sharing suggestions and resources to help individuals manage the disease. [More]

New NxStage Kidney Care center opens in Oak Brook, Illinois

NxStage Kidney Care, Inc., a subsidiary of NxStage Medical, Inc., is proud to host the grand opening ceremony of its Oak Brook, Illinois center at 1600 W. 16th Street on November 20, 2014 from 3pm – 7pm. [More]